Therapeutic Vaccine

About 2A Pharma

2A Pharma is a private, clinical-stage biotech leveraging its patented AAVLP platform to develop next-generation vaccines. Its lead program is a prophylactic HPV vaccine in Phase 1, with a pipeline targeting infectious diseases, EpCAM+ cancers, and autoimmune conditions like vitiligo. The company's technology aims to offer broader coverage, improved safety, and lower production costs compared to existing vaccines, positioning it to address multi-billion-dollar unmet medical needs.

About 2A Pharma

2A Pharma is a private, clinical-stage biotech leveraging its patented AAVLP platform to develop next-generation vaccines. Its lead program is a prophylactic HPV vaccine in Phase 1, with a pipeline targeting infectious diseases, EpCAM+ cancers, and autoimmune conditions like vitiligo. The company's technology aims to offer broader coverage, improved safety, and lower production costs compared to existing vaccines, positioning it to address multi-billion-dollar unmet medical needs.

Therapeutic Areas